STATEN ISLAND, N.Y., Dec. 9, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule ...
Acurx (ACXP) Pharmaceuticals announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA communications. Acurx’s Executive Chairman, Bob DeLuccia, ...
Many people with tuberculosis stay in the latent infection stage, but some develop the active disease. Both stages are treatable. Tuberculosis (TB) is a bacterial infection that usually affects the ...
MRSA is a type of staph highly resistant to a common class of antibiotics. Many people carry MRSA harmlessly on their skin or inside their noses. However, if the bacteria penetrates the skin, it can ...
Scientists assess bacterial growth trajectories to better predict infectious capacity and the conditions that aid proliferation. This article explores the key factors that influence bacterial ...
SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it ...
Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the Australian biotech to point to the anti-infective's potential to counter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results